In contrast, FGFR-2 has been shown to be downregulated in pituitary adenomas due to FGFR-2 promoter methylation; however, this has not been clinically assessed in relation to tumor invasiveness or aggressiveness [63]. Here, FGFR2 is linked to pituitary gland adenoma.